Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | prostaglandin I2 (prostacyclin) receptor (IP) | Starlite/ChEMBL | References |
Homo sapiens | thymidine phosphorylase | Starlite/ChEMBL | References |
Homo sapiens | prostaglandin F receptor (FP) | Starlite/ChEMBL | References |
Homo sapiens | prostaglandin D2 receptor (DP) | Starlite/ChEMBL | References |
Homo sapiens | prostaglandin E receptor 1 (subtype EP1), 42kDa | Starlite/ChEMBL | References |
Homo sapiens | prostaglandin E receptor 2 (subtype EP2), 53kDa | Starlite/ChEMBL | References |
Homo sapiens | prostaglandin E receptor 4 (subtype EP4) | Starlite/ChEMBL | References |
Homo sapiens | prostaglandin E receptor 3 (subtype EP3) | Starlite/ChEMBL | References |
Species | Potential target | Known druggable target/s | Ortholog Group |
---|---|---|---|
Mycobacterium tuberculosis | Probable thymidine phosphorylase DeoA (tdrpase) (pyrimidine phosphorylase) | Get druggable targets OG5_131632 | All targets in OG5_131632 |
Echinococcus multilocularis | thymidine phosphorylase | Get druggable targets OG5_131632 | All targets in OG5_131632 |
Mycobacterium ulcerans | thymidine phosphorylase | Get druggable targets OG5_131632 | All targets in OG5_131632 |
Echinococcus granulosus | thymidine phosphorylase | Get druggable targets OG5_131632 | All targets in OG5_131632 |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Echinococcus multilocularis | rhodopsin orphan GPCR | prostaglandin D2 receptor (DP) | 359 aa | 312 aa | 23.1 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Schistosoma mansoni | family S9 non-peptidase homologue (S09 family) | 0.0309 | 0.2087 | 0.5 |
Trypanosoma brucei | C-8 sterol isomerase, putative | 0.0368 | 0.3118 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0309 | 0.2087 | 0.6695 |
Mycobacterium leprae | Probable anthranilate phosphoribosyltransferase TrpD | 0.0216 | 0.0483 | 0.5 |
Mycobacterium tuberculosis | Probable thymidine phosphorylase DeoA (tdrpase) (pyrimidine phosphorylase) | 0.0765 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0309 | 0.2087 | 0.6695 |
Echinococcus multilocularis | thymidine phosphorylase | 0.0765 | 1 | 1 |
Brugia malayi | ERG2 and Sigma1 receptor like protein | 0.0368 | 0.3118 | 1 |
Mycobacterium ulcerans | thymidine phosphorylase | 0.0765 | 1 | 1 |
Loa Loa (eye worm) | acetylcholinesterase 1 | 0.0309 | 0.2087 | 0.6695 |
Loa Loa (eye worm) | hypothetical protein | 0.0368 | 0.3118 | 1 |
Trypanosoma cruzi | C-8 sterol isomerase, putative | 0.0368 | 0.3118 | 0.5 |
Loa Loa (eye worm) | carboxylesterase | 0.0309 | 0.2087 | 0.6695 |
Leishmania major | C-8 sterol isomerase-like protein | 0.0368 | 0.3118 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Ki (binding) | = 0.025 uM | Affinity at human Prostanoid EP3 receptor in the human embryonic kidney (HEK) 293 cell line. | ChEMBL. | 14552786 |
Ki (binding) | = 0.025 uM | Binding affinity at human Prostanoid EP3 receptor. | ChEMBL. | 12182865 |
Ki (binding) | = 0.025 uM | Affinity at human Prostanoid EP3 receptor in the human embryonic kidney (HEK) 293 cell line. | ChEMBL. | 14552786 |
Ki (binding) | = 0.025 uM | Binding affinity at human Prostanoid EP3 receptor. | ChEMBL. | 12182865 |
Ki (binding) | = 0.77 uM | Inhibitory constant of the compound was determined against Prostanoid TP receptor | ChEMBL. | 12182865 |
Ki (binding) | = 0.77 uM | Inhibitory constant of the compound was determined against Prostanoid TP receptor | ChEMBL. | 12182865 |
Ki (binding) | = 0.83 uM | Inhibitory constant of the compound was determined against Prostanoid DP receptor | ChEMBL. | 12182865 |
Ki (binding) | = 0.83 uM | Inhibitory constant of the compound was determined against Prostanoid DP receptor | ChEMBL. | 12182865 |
Ki (binding) | = 3.7 uM | Affinity at human Prostanoid EP4 receptor in the human embryonic kidney (HEK) 293 cell line. | ChEMBL. | 14552786 |
Ki (binding) | = 3.7 uM | Binding affinity at human Prostanoid EP4 receptor. | ChEMBL. | 12182865 |
Ki (binding) | = 3.7 uM | Affinity at human Prostanoid EP4 receptor in the human embryonic kidney (HEK) 293 cell line. | ChEMBL. | 14552786 |
Ki (binding) | = 3.7 uM | Binding affinity at human Prostanoid EP4 receptor. | ChEMBL. | 12182865 |
Ki (binding) | = 7.3 uM | Inhibitory constant of the compound was determined against Prostanoid IP receptor | ChEMBL. | 12182865 |
Ki (binding) | = 7.3 uM | Inhibitory constant of the compound was determined against Prostanoid IP receptor | ChEMBL. | 12182865 |
Ki (binding) | = 8.1 uM | Affinity at human Prostanoid EP1 receptor in the human embryonic kidney (HEK) 293 cell line. | ChEMBL. | 14552786 |
Ki (binding) | = 8.1 uM | Affinity at human Prostanoid EP1 receptor in the human embryonic kidney (HEK) 293 cell line. | ChEMBL. | 14552786 |
Ki (binding) | = 8.2 uM | Binding affinity at human Prostanoid EP1 receptor. | ChEMBL. | 12182865 |
Ki (binding) | = 8.2 uM | Binding affinity at human Prostanoid EP1 receptor. | ChEMBL. | 12182865 |
Ki (binding) | = 10 uM | Affinity at human Prostanoid EP2 receptor in the human embryonic kidney (HEK) 293 cell line. | ChEMBL. | 14552786 |
Ki (binding) | = 10 uM | Affinity at human Prostanoid EP2 receptor in the human embryonic kidney (HEK) 293 cell line. | ChEMBL. | 14552786 |
Ki (binding) | = 17 uM | Inhibitory constant of the compound was determined against Prostanoid FP receptor | ChEMBL. | 12182865 |
Ki (binding) | = 17 uM | Inhibitory constant of the compound was determined against Prostanoid FP receptor | ChEMBL. | 12182865 |
Ki (binding) | = 27 uM | Binding affinity at human Prostanoid EP2 receptor. | ChEMBL. | 12182865 |
Ki (binding) | = 27 uM | Binding affinity at human Prostanoid EP2 receptor. | ChEMBL. | 12182865 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
2 literature references were collected for this gene.